OTC:MGROF MustGrow Biologics (MGROF) Stock Price, News & Analysis C$1.07 0.00 (0.00%) As of 01/21/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlines About MustGrow Biologics Stock (OTC:MGROF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get MustGrow Biologics alerts:Sign Up Key Stats Today's RangeC$1.07▼C$1.0750-Day RangeC$0.75▼C$1.4752-Week RangeC$0.41▼C$1.73VolumeN/AAverage Volume969 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewMustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard seeds. It provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home and garden markets, as well as agriculture markets where glyphosate has been banned; and suppress sprouting, and treat disease and pathogen for storage and food preservation markets. The company also offers TerraMG, a mustard-derived soil biopesticide technology. In addition, it is developing TerraSante, an organic soil amendment and biofertility technology. The company was formerly known as Duport Capital Ltd. and changed its name to MustGrow Biologics Corp. in March 2018. MustGrow Biologics Corp. was incorporated in 2014 and is headquartered in Saskatoon, Canada.Read More… Receive MGROF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MustGrow Biologics and its competitors with MarketBeat's FREE daily newsletter. Email Address MGROF Stock News HeadlinesMustGrow Biologics announces closing of financing roundJanuary 17, 2025 | proactiveinvestors.comMustGrow Biologics Raises $2.6 Million through Private PlacementJanuary 16, 2025 | tipranks.comA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. January 22, 2025 | Porter & Company (Ad)MustGrow Biologics expands revenue, enhances sales reach through NexusBioAg acquisition, analysts believeJanuary 6, 2025 | proactiveinvestors.comMustGrow Biologics expands revenue, enhances sales reach through NexusBioAg acquisition, analysts believeJanuary 6, 2025 | proactiveinvestors.comMustGrow Biologics CEO discusses NexusBio acquisition and future plans – ICYMIJanuary 4, 2025 | proactiveinvestors.comMustGrow Biologics CEO discusses NexusBio acquisition and future plans – ICYMIJanuary 4, 2025 | proactiveinvestors.comMustGrow shares surge after NexusBioAg acquisition finalizedJanuary 2, 2025 | proactiveinvestors.comSee More Headlines MGROF Stock Analysis - Frequently Asked Questions How have MGROF shares performed this year? MustGrow Biologics' stock was trading at C$0.92 on January 1st, 2025. Since then, MGROF shares have increased by 15.8% and is now trading at C$1.07. View the best growth stocks for 2025 here. How do I buy shares of MustGrow Biologics? Shares of MGROF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTC SectorBasic Materials Industry Agricultural Inputs Sub-IndustryN/A Current SymbolOTC:MGROF CUSIPN/A CIKN/A Webwww.mustgrow.ca Phone306-668-2652FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (OTC:MGROF) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTexas embraces new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredNow that Trump’s be inaugurated, this day will be key (mark your calendar)Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredThe Stock I’m Calling My #1 of the DecadeThe stock I reveal right here is my #1 stock of the decade. In fact, it might be my favorite stock ever. ...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MustGrow Biologics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share MustGrow Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.